AB-Cube
Founded in 2006, AB-Cube revolutionised the life sciences and international healthcare industry with a cloud-based vigilance solution for management of adverse events. They offer a wide range of dedicated solutions like pharmacovigilance, medical device safety, nutrivigilance and CosmEthics® for cosmetovigilance.
They have a diverse international client base, consisting of organisations, academia, CROs and pharmaceutical companies, who are proud to collaborate with AB-Cube for their pharmacovigilance needs.
Learn more: www.ab-cube.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
March 31, 2026
Applied Clinical Trials Online Clinical trials are growing more complex, and this trend will increase. Sponsors now expect seamless data capture from electronic systems, labs, wearables, patient-reported outcomes, and third-party sources, all feeding pivotal datasets. As data sources become more diverse and voluminous, the risk of integration and process errors rises. Small oversights in data […]
March 31, 2026
Medtech Dive FDA exempts more wearable, AI features from oversight In a pair of guidance documents, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight. By: Elise Reuter • Published Jan. 8, 2026 The Food and Drug Administration released two final guidance documents that would […]
February 26, 2026
During the EUCROF 2026 gala dinner in Amsterdam, in front of 300+ participants from the European clinical research ecosystem, the xShare project Open Call Awards for Clinical Research were officially presented. We are extremely proud that Telemedicine Technologies contributed to three complementary xShare Open Call projects (out of 10), all recognised for their quality, innovation […]